Please assess the completion status of the following clinical trial:

Trial Title: DermaClose DUKE Fasciotomy and Wound Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient is at least 18 years of age at the time of consent.~* Patient with a full thickness acute wound(s) of the skin:~  1. On either the upper or lower extremity (including four-compartment leg fasciotomy), in whom DermaClose and/or DermaClose XL is applied during surgery, OR~ 2. Undergoing a four-compartment leg fasciotomy requiring conventional wound dressing.~* Patient has signed a written informed consent form (ICF) per 21 Code of Federal Regulations (CFR) Part 50.55(e).~Exclusion Criteria:~* Patient in whom the product was used off-label (except for patients who have the device on for longer than 14 days)~* Patient with wound(s) that exhibit any of the following:~  * Ischemic tissue,~ * Infected tissue,~ * Acute burned tissue,~ * Fragile tissue at the edges of the wound(s).~* Patient, who in surgeon's opinion, does not fit the criteria for this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Wound on either the upper or lower extremity with DermaClose and/or DermaClose XL (Type: None): Non-fasciotomy
- Wound undergoing fasciotomy with DermaClose and/or DermaClose XL (Type: None): None
- Wound undergoing fasciotomy with conventional wound dressings (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).